2-naphthoylethyltrimethylammonium has been researched along with Allergic Encephalomyelitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jacobo, SA; Kumar, V; LaJevic, M; Malhotra, SV; Pandrala, M; Zabel, BA | 1 |
| Burke, TM; Butcher, EC; Dang, T; Graham, KL; Lewén, S; Sobel, RA; Zabel, BA; Zhang, JV; Zoudilova, M | 1 |
2 other study(ies) available for 2-naphthoylethyltrimethylammonium and Allergic Encephalomyelitis
| Article | Year |
|---|---|
Novel CMKLR1 Inhibitors for Application in Demyelinating Disease.
Topics: Animals; Cell Line, Tumor; Dimethyl Fumarate; Encephalomyelitis, Autoimmune, Experimental; Female; Hepatocytes; Humans; Immunosuppressive Agents; Mice; Mice, Inbred C57BL; Microsomes, Liver; Naphthalenes; Pregnane X Receptor; Quaternary Ammonium Compounds; Receptors, Chemokine; Structure-Activity Relationship | 2019 |
A novel CMKLR1 small molecule antagonist suppresses CNS autoimmune inflammatory disease.
Topics: Animals; Arrestins; beta-Arrestins; Brain; Cell Movement; Chemokines; Drug Evaluation, Preclinical; Drug Stability; Encephalomyelitis, Autoimmune, Experimental; Female; Humans; Intercellular Signaling Peptides and Proteins; Leukocytes; Mice; Mice, Inbred C57BL; Naphthalenes; Quaternary Ammonium Compounds; Receptors, Chemokine; Receptors, G-Protein-Coupled; Safety; Spinal Cord; Structure-Activity Relationship | 2014 |